Sun Pharmaceutical Industries Ltd
BSE:524715
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sun Pharmaceutical Industries Ltd
BSE:524715
|
IN |
Intrinsic Value
The intrinsic value of 
Sun Pharmaceutical Industries Ltd (524715) under the Base Case is 1 688.61 INR per share.
Compared with the current market price of 1 825.35 INR, the stock appears
Overvalued by 7% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Sun Pharmaceutical Industries Does
Sun Pharmaceutical Industries is a drug maker. It develops, manufactures, and sells prescription medicines, over-the-counter products, and active pharmaceutical ingredients, which are the core chemical ingredients used in making drugs. Its lineup includes generic medicines as well as branded specialty treatments for conditions such as skin diseases, eye care, and chronic illnesses.
- Headquarters
- India IN
- Employees
- 43 000
- IPO date
- Jan 1, 1994
Sun Pharmaceutical Industries has a narrow economic moat
Legal protection for selected medicines prevents rivals from selling direct copies, giving Sun Pharma room to earn profits beyond those available from ordinary generic drugs. This protection applies to part of its portfolio, while its broader generic business faces substantial competition.
Read the full moat analysis
Revenue & Expenses Breakdown
Sun Pharmaceutical Industries Ltd
Earnings Waterfall
Sun Pharmaceutical Industries Ltd
The intrinsic value for Sun Pharmaceutical Industries Ltd (524715) under the Base Case is 1 688.61 INR.
Compared with the current market price of 1 825.35 INR, the stock appears Overvalued by 7% .
